---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-244191"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2025-10-21T23:59:59+00:00"
generated_at: "2026-05-17T02:57:55.035546+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Q3 revenue $50.1B (+12% YoY), GAAP EPS $5.32, adj. EPS $6.03; FY guidance reaffirmed

## Summary
- Health Benefits operating revenue $42.2B (+10% YoY), operating margin 1.4%, medical membership ~45.4M.
- Carelon revenue $18.3B (+33% YoY), operating margin 4.2%; driven by acquisitions and pharmacy growth.
- Benefit expense ratio 91.3% (up 180 bps YoY) on elevated Medicare Part D trend; operating expense ratio improved 130 bps to 10.5%.
- Year-to-date operating cash flow $4.2B; Q3 share repurchases 2.9M shares at $303.48 avg price, $875M total.
- Dividend of $1.71/share declared, payable Dec 19, 2025 to holders of record Dec 5, 2025.

## SEC filing metadata
- accession: 0001193125-25-244191
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2025-10-21T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000119312525244191/0001193125-25-244191-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000119312525244191/d270615d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-244191
- JSON: https://secwatch.observer/filing/0001193125-25-244191.json
- Plain text: https://secwatch.observer/filing/0001193125-25-244191.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.